Please Scroll Down to See Forums Below 
Re: price check
i used BTG my first time out because i was afraid of complications and side effects so i went with the human grade because it was the most sterile...
i am using leoffler var right now.. i like them better for a couple of reasons
1) 5mg tabs instead of BTG 2.5mg = CHEAPER ($180)
2) they seem to be more potent and working better for me.. my strength gains are better, it is not interfereing with my sex drive like BTG did (depressed my drive a tad) and i am not having any other female problems..
Below is an exerpt:
Dec. 5, 1995 -- Bio-Technology General Corp. (NASDAQ: BTGC) today announced its first major U.S. drug launch: Oxandrin(R) (oxandrolone), an oral anabolic agent indicated as adjunctive therapy to promote weight gain after weight loss following extensive surgery, chronic infections, or severe trauma. Oxandrin(R) is also indicated for patients who, without definite pathophysiologic reasons, fail to gain or maintain normal weight.
For reasons that are not clear, many chronic and acute disease processes are known to cause involuntary weight loss. These include certain types of cancer, AIDS, burns, chronic obstructive pulmonary disease, gastrointestinal disorders, renal failure and sepsis. Regardless of the etiology, these disorders result in a state of malnutrition which depletes lean body mass. Such involuntary weight loss can directly contribute to mortality if not stopped or reversed.
yea.. that is the normal pricemuscle_geek said:
i used BTG my first time out because i was afraid of complications and side effects so i went with the human grade because it was the most sterile...
i am using leoffler var right now.. i like them better for a couple of reasons
1) 5mg tabs instead of BTG 2.5mg = CHEAPER ($180)
2) they seem to be more potent and working better for me.. my strength gains are better, it is not interfereing with my sex drive like BTG did (depressed my drive a tad) and i am not having any other female problems..
Below is an exerpt:
Dec. 5, 1995 -- Bio-Technology General Corp. (NASDAQ: BTGC) today announced its first major U.S. drug launch: Oxandrin(R) (oxandrolone), an oral anabolic agent indicated as adjunctive therapy to promote weight gain after weight loss following extensive surgery, chronic infections, or severe trauma. Oxandrin(R) is also indicated for patients who, without definite pathophysiologic reasons, fail to gain or maintain normal weight.
For reasons that are not clear, many chronic and acute disease processes are known to cause involuntary weight loss. These include certain types of cancer, AIDS, burns, chronic obstructive pulmonary disease, gastrointestinal disorders, renal failure and sepsis. Regardless of the etiology, these disorders result in a state of malnutrition which depletes lean body mass. Such involuntary weight loss can directly contribute to mortality if not stopped or reversed.
